Health / Health News

    The tuberculosis pathogen releases its toxin via a novel protein transport system

    Six years ago, scientist Michael Niederweis described the first toxin ever found for the deadly pathogen Mycobacterium tuberculosis. The toxin, tuberculosis necrotizing toxin or TNT, became the founding member of a novel class of previously unrecognized toxins present in more than 600 bacterial and fungal species.



    Scanning electron micrograph of Mycobacterium tuberculosis bacteria, which cause TB. Photo: NIAID


    As M. tuberculosis bacteria survive and grow inside their human host, the toxin is released. For 132 years, the lack of an identified toxin in M. tuberculosis contrasted with nearly all other pathogenic bacteria whose toxins contribute to illness or death. M. tuberculosis infects 9 million people a year and kills more than 1 million.

    Now, in a new work, the University of Alabama at Birmingham researcher and his colleagues describe how two small ESX proteins made by the M. tuberculosis bacteria mediate the secretion of TNT by pore formation in the membranes that envelop the bacteria.

    The finding may have broad application because a distinctive three-amino acid motif found on EsxE and EsxF -- tryptophan/any-amino-acid/glycine, known in shorthand as WXG -- is also found on many other small mycobacterium proteins and on the large WXG100 superfamily of bacterial proteins that resemble EsxE and EsxF.

    "Here, we show for the first time that small Esx proteins of the WXG100 family have an important molecular function by mediating toxin secretion," said Niederweis. "Our study represents a major advancement in understanding TNT and other proteins in M. tuberculosis." (National Science Foundation)

    MAY 8, 2021



    YOU MAY ALSO LIKE

    Experiencing bullying and forms of aggression in late adolescence and early adulthood is linked (...)
    Researchers have created a dietary tool to aid healthy food choices and cut climate change risks.
    Biodiversity loss increases exposure to new and established pathogens.
    Scientists have made a promising step towards developing a new drug for treating acute myeloid leukaemia, a rare blood disorder.
    Study in mice suggests lymphatic boost could help reduce amyloid buildup.
    Scientists at the University of Cambridge have shown in animal studies that (...)

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact